z-logo
open-access-imgOpen Access
INTRAVITREAL NESVACUMAB (ANTIANGIOPOIETIN 2) PLUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA
Author(s) -
David M. Brown,
David S. Boyer,
Karl G. Csaky,
Robert Vitti,
Lorah Perlee,
Karen Chu,
Friedrich Asmus,
Sérgio Leal,
Oliver Zeitz,
Yenchieh Cheng,
Thomas Schmelter,
Jeffrey S. Heier
Publication year - 2022
Publication title -
retina
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.24
H-Index - 120
eISSN - 1539-2864
pISSN - 0275-004X
DOI - 10.1097/iae.0000000000003441
Subject(s) - aflibercept , medicine , diabetic macular edema , diabetic retinopathy , ophthalmology , visual acuity , macular edema , surgery , diabetes mellitus , bevacizumab , chemotherapy , endocrinology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here